IT1246383B - Metodo per il mascheramento del sapore di farmaci - Google Patents

Metodo per il mascheramento del sapore di farmaci

Info

Publication number
IT1246383B
IT1246383B IT02005590A IT2005590A IT1246383B IT 1246383 B IT1246383 B IT 1246383B IT 02005590 A IT02005590 A IT 02005590A IT 2005590 A IT2005590 A IT 2005590A IT 1246383 B IT1246383 B IT 1246383B
Authority
IT
Italy
Prior art keywords
pct
taste
drugs
sec
masking
Prior art date
Application number
IT02005590A
Other languages
English (en)
Other versions
IT9020055A0 (it
IT9020055A1 (it
Inventor
Luigi Giovanni Mapelli
Marco Giuseppe Raffael Marconi
Marco Zema
Original Assignee
Eurand Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Int filed Critical Eurand Int
Publication of IT9020055A0 publication Critical patent/IT9020055A0/it
Priority to IT02005590A priority Critical patent/IT1246383B/it
Priority to JP50687791A priority patent/JP3193041B2/ja
Priority to AU76812/91A priority patent/AU635133B2/en
Priority to US07/776,329 priority patent/US5409711A/en
Priority to EP91907609A priority patent/EP0477333B1/en
Priority to PCT/EP1991/000689 priority patent/WO1991016043A1/en
Priority to KR1019910701886A priority patent/KR0164863B1/ko
Priority to DK91907609.1T priority patent/DK0477333T3/da
Priority to CA002058946A priority patent/CA2058946C/en
Priority to ES91907609T priority patent/ES2048594T3/es
Priority to SU915010753A priority patent/RU2085190C1/ru
Priority to DE91907609T priority patent/DE69100991T2/de
Priority to AT91907609T priority patent/ATE99927T1/de
Priority to ZA912793A priority patent/ZA912793B/xx
Priority to NZ237824A priority patent/NZ237824A/en
Priority to PT97369A priority patent/PT97369B/pt
Priority to IE127291A priority patent/IE64274B1/en
Publication of IT9020055A1 publication Critical patent/IT9020055A1/it
Application granted granted Critical
Publication of IT1246383B publication Critical patent/IT1246383B/it
Priority to HK12495A priority patent/HK12495A/en
Priority to SA99191025A priority patent/SA99191025A/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT02005590A 1990-04-17 1990-04-17 Metodo per il mascheramento del sapore di farmaci IT1246383B (it)

Priority Applications (19)

Application Number Priority Date Filing Date Title
IT02005590A IT1246383B (it) 1990-04-17 1990-04-17 Metodo per il mascheramento del sapore di farmaci
SU915010753A RU2085190C1 (ru) 1990-04-17 1991-04-09 Твердая лекарственная форма для орального введения фармацевтически активных веществ, имеющих неблагоприятные органолептические свойства
AT91907609T ATE99927T1 (de) 1990-04-17 1991-04-09 Pharmazeutische formulierungen.
US07/776,329 US5409711A (en) 1990-04-17 1991-04-09 Pharmaceutical formulations
EP91907609A EP0477333B1 (en) 1990-04-17 1991-04-09 Pharmaceutical formulations
PCT/EP1991/000689 WO1991016043A1 (en) 1990-04-17 1991-04-09 Pharmaceutical formulations
KR1019910701886A KR0164863B1 (ko) 1990-04-17 1991-04-09 약제학적 제형
DK91907609.1T DK0477333T3 (da) 1990-04-17 1991-04-09 Farmaceutiske præparater
CA002058946A CA2058946C (en) 1990-04-17 1991-04-09 Formulations for the oral administration of drugs with masked taste
ES91907609T ES2048594T3 (es) 1990-04-17 1991-04-09 Formulaciones farmaceuticas.
JP50687791A JP3193041B2 (ja) 1990-04-17 1991-04-09 医薬製剤
DE91907609T DE69100991T2 (de) 1990-04-17 1991-04-09 Pharmazeutische formulierungen.
AU76812/91A AU635133B2 (en) 1990-04-17 1991-04-09 Pharmaceutical formulations
ZA912793A ZA912793B (en) 1990-04-17 1991-04-15 Pharmaceutical formulations
NZ237824A NZ237824A (en) 1990-04-17 1991-04-15 Formulation for oral administration comprising a core of active ingredient coated by a polymer soluble at ph greater than 5 and containing an acidic compound to prevent dissolution of the coating in the mouth
PT97369A PT97369B (pt) 1990-04-17 1991-04-15 Processo para a preparacao de formulacoes farmaceutica na qual o sabor do medicamento e disfarcado por meio de revestimento do medicamento com uma membrana polimerica
IE127291A IE64274B1 (en) 1990-04-17 1991-04-16 Pharmaceutical formulations
HK12495A HK12495A (en) 1990-04-17 1995-01-26 Pharmaceutical formulations
SA99191025A SA99191025A (ar) 1990-04-17 1999-02-01 تراكيب صيدلية

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02005590A IT1246383B (it) 1990-04-17 1990-04-17 Metodo per il mascheramento del sapore di farmaci

Publications (3)

Publication Number Publication Date
IT9020055A0 IT9020055A0 (it) 1990-04-17
IT9020055A1 IT9020055A1 (it) 1991-10-17
IT1246383B true IT1246383B (it) 1994-11-18

Family

ID=11163454

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02005590A IT1246383B (it) 1990-04-17 1990-04-17 Metodo per il mascheramento del sapore di farmaci

Country Status (19)

Country Link
US (1) US5409711A (it)
EP (1) EP0477333B1 (it)
JP (1) JP3193041B2 (it)
KR (1) KR0164863B1 (it)
AT (1) ATE99927T1 (it)
AU (1) AU635133B2 (it)
CA (1) CA2058946C (it)
DE (1) DE69100991T2 (it)
DK (1) DK0477333T3 (it)
ES (1) ES2048594T3 (it)
HK (1) HK12495A (it)
IE (1) IE64274B1 (it)
IT (1) IT1246383B (it)
NZ (1) NZ237824A (it)
PT (1) PT97369B (it)
RU (1) RU2085190C1 (it)
SA (1) SA99191025A (it)
WO (1) WO1991016043A1 (it)
ZA (1) ZA912793B (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111388444A (zh) * 2020-03-18 2020-07-10 北京鑫开元医药科技有限公司 一种罗红霉素颗粒及其制备方法

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2704146B1 (fr) * 1993-04-19 1995-07-13 Cripdom Microcapsules d'acide acétylsalicylique à libération contrôlée.
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
US8071128B2 (en) * 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
DE19648576C2 (de) * 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
CA2305179A1 (en) * 1997-09-30 1999-04-08 Daiichi Pharmaceutical Co., Ltd. Oral administration preparation
RU2222815C2 (ru) * 1997-10-09 2004-01-27 Дексел Фарма Текнолоджис Элтиди. Лекарственная форма для доставки и непосредственного локализованного освобождения желаемого агента в желудочно-кишечном тракте животного и способ доставки желаемого агента в желудочно-кишечный тракт животного (варианты)
BR9705470A (pt) * 1997-11-12 1999-07-06 Ind Quimica E Farmaceutica Sch Processo para a preparação de uma composição farmaceutica oral composição farmaceutica oral e kit compreendendo uma composição farmacêutica
NZ333474A (en) 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
JP3143433B2 (ja) * 1998-07-07 2001-03-07 三基商事株式会社 マスキング組成物
FR2781152B1 (fr) * 1998-07-20 2001-07-06 Permatec Tech Ag Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation
DE19835823A1 (de) * 1998-08-10 1999-10-07 Lindopharm Gmbh Pharmazeutische Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung sowie aus ihr hergestellte wässerige Suspension
FR2793690B1 (fr) * 1999-03-30 2003-01-03 Cll Pharma Formulations pharmaceutiques en macrolides seuls ou associes a d'autres principes actifs et leur utilisation en therapeutique
BR0009557A (pt) 1999-04-06 2002-05-28 Ethypharm Lab Prod Ethiques Suspensão farmacêutica para beber de ibuprofeno
IN191239B (it) 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
CN1288730A (zh) * 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
JP3718398B2 (ja) * 2000-01-11 2005-11-24 信越化学工業株式会社 フィルムコーティング剤及び経口固形製剤
US7999118B2 (en) 2000-01-18 2011-08-16 Albemarle Corporation Process for producing N-halogenated hydantoins
US6508954B1 (en) * 2000-01-18 2003-01-21 Albemarle Corporation 1,3-dibromo-5,5-dimethylhydantoin of enhanced properties
US20050049420A1 (en) * 2000-01-18 2005-03-03 Elnagar Hassan Y. Process for producing N-halogenated organic compounds
AU2578701A (en) * 2000-02-29 2001-09-12 Teva Pharma Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
KR20030011797A (ko) * 2000-03-28 2003-02-11 바이오케미 게젤샤프트 엠베하 맛이 차폐된 과립형 입자
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
PT1276470E (pt) 2000-04-20 2007-08-13 Novartis Ag Composição de revestimento para dissimular o sabor
US7223421B2 (en) * 2000-06-30 2007-05-29 Mcneil-Ppc, Inc. Teste masked pharmaceutical particles
EP1642885B1 (en) 2000-08-29 2009-11-11 Biocon Limited Use of a pharmaceutical composition containing a para-aminophenyl acetic acid derivative for treating inflammatory conditions of the gastrointestinal tract
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US20020119196A1 (en) * 2000-12-21 2002-08-29 Narendra Parikh Texture masked particles containing an active ingredient
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US6986910B2 (en) * 2001-06-28 2006-01-17 Albemarle Corporation Microbiological control in poultry processing
US20030077365A1 (en) * 2001-06-28 2003-04-24 Howarth Jonathan N. Environmentally-friendly microbiological and microbiocidal control in aqueous systems
US6919364B2 (en) * 2001-06-28 2005-07-19 Solution Biosciences, Inc. Microbiological control in animal processing
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
GB0123400D0 (en) * 2001-09-28 2001-11-21 Novartis Ag Organic compounds
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
US20090178587A9 (en) * 2001-10-09 2009-07-16 Nalepa Christopher J Control of biofilms in industrial water systems
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
DE10152351B4 (de) * 2001-10-18 2005-09-22 Schering Ag Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat
US20030118329A1 (en) * 2001-12-21 2003-06-26 Pere Obrador Video indexing using high resolution still images
RU2207120C1 (ru) * 2001-12-29 2003-06-27 Закрытое акционерное общество "Брынцалов-А" Лекарственное средство брилид антибиотического действия
WO2003077842A2 (en) * 2002-03-12 2003-09-25 Bristol-Myers Squibb Company Palatable oral suspension and method
DE60323474D1 (de) * 2002-04-09 2008-10-23 Flamel Tech Sa Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin
MXPA04009968A (es) 2002-04-09 2004-12-13 Flamel Tech Sa Formulacion farmaceutica oral bajo forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de principio (s) activo (s).
US6958161B2 (en) * 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
EP1545468A4 (en) * 2002-09-20 2007-06-20 Alpharma Inc SUSTAINED RELEASE OPIOID PREPARATIONS AND METHODS OF USE
US20060073216A1 (en) * 2002-12-26 2006-04-06 Solution Biosciences, Inc. Compositions and methods for control of bovine mastitis
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
RU2222333C1 (ru) * 2003-03-06 2004-01-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция с антибактериальной активностью и способ ее получения
RU2240112C1 (ru) * 2003-06-09 2004-11-20 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Лекарственная форма, обладающая бактериостатическим действием, и способ ее изготовления
US20040265446A1 (en) * 2003-06-24 2004-12-30 Mcnaughton James L. Microbiocidal control in the processing of poultry
US20040265445A1 (en) * 2003-06-24 2004-12-30 Liimatta Eric W. Microbiocidal control in the processing of poultry
US7901276B2 (en) 2003-06-24 2011-03-08 Albemarle Corporation Microbiocidal control in the processing of meat-producing four-legged animals
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
US7417037B2 (en) * 2004-01-20 2008-08-26 The Board Of Regents Of The University Of Oklahoma Compositions and methods of treatment for inflammatory diseases
HUE028158T2 (en) 2004-07-07 2016-12-28 Biocon Ltd Synthesis of bound immunoregulatory compounds
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) * 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
GB2419094A (en) 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
AU2005299490C1 (en) 2004-10-21 2012-01-19 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
JP2007031407A (ja) 2005-07-29 2007-02-08 Shin Etsu Chem Co Ltd 低置換度セルロースエーテル含有コーティング用組成物及び不快な味が隠蔽されたフィルムコーティング製剤
JP2009518014A (ja) * 2005-12-01 2009-05-07 ソリユーシヨン・バイオサイエンシズ・インコーポレーテツド 食肉用四足動物の処理における殺菌剤コントロール
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
CN101563074B (zh) * 2006-10-20 2012-11-07 麦克内尔-Ppc股份有限公司 乙酰氨基酚/布洛芬组合
US20080113021A1 (en) * 2006-10-25 2008-05-15 Robert Shen Ibuprofen composition
CN101380474B (zh) * 2007-09-06 2012-07-25 北京大学 用于口服制剂的pH敏感性固体药物组合物及制备方法
CN102988318A (zh) * 2008-11-25 2013-03-27 田边三菱制药株式会社 口腔速崩片及其制备方法
KR101765357B1 (ko) 2009-12-02 2017-08-04 아데어 파마수티컬스 에스.알.엘. 펙소페나딘 마이크로캡슐 및 그것을 함유하는 조성물
AR079862A1 (es) * 2010-01-08 2012-02-22 Eurand Inc Composicion de topiramato con sabor enmascarado, un comprimido desintegrable oralmente que comprende la misma y metodo de preparacion
JP6003890B2 (ja) * 2011-06-10 2016-10-05 ニプロ株式会社 口腔内崩壊錠の製造方法
HK1212889A1 (zh) 2012-09-18 2016-06-24 Mcneil-Ppc, Inc. 包含低熔点丙酸衍生物颗粒的缓释口服剂型
CA2884119A1 (en) 2012-09-18 2014-03-27 Mcneil-Ppc, Inc. Low melting propionic acid derivative particles for use in oral dosage forms
US9820894B2 (en) 2013-03-22 2017-11-21 The Procter & Gamble Company Disposable absorbent articles
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
RU2744270C2 (ru) * 2015-12-28 2021-03-04 ЭсЭсПи КО., ЛТД., ДЖАПАН Прессованный фармацевтический препарат
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US10828208B2 (en) 2016-11-21 2020-11-10 The Procte & Gamble Company Low-bulk, close-fitting, high-capacity disposable absorbent pant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
JPS5858145A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
FR2514261B1 (fr) * 1981-10-08 1986-08-22 Aec Chim Organ Biolog Nouvelle composition pour l'enrobage des aliments et des medicaments et granules ainsi enrobes
US4894240A (en) * 1983-12-22 1990-01-16 Elan Corporation Plc Controlled absorption diltiazem formulation for once-daily administration
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111388444A (zh) * 2020-03-18 2020-07-10 北京鑫开元医药科技有限公司 一种罗红霉素颗粒及其制备方法

Also Published As

Publication number Publication date
DE69100991T2 (de) 1994-05-05
PT97369B (pt) 1998-08-31
CA2058946C (en) 2001-11-20
JP3193041B2 (ja) 2001-07-30
IE64274B1 (en) 1995-07-26
KR0164863B1 (ko) 1999-01-15
ATE99927T1 (de) 1994-01-15
US5409711A (en) 1995-04-25
SA99191025A (ar) 2005-12-03
EP0477333A1 (en) 1992-04-01
ZA912793B (en) 1992-12-30
AU635133B2 (en) 1993-03-11
IT9020055A0 (it) 1990-04-17
RU2085190C1 (ru) 1997-07-27
WO1991016043A1 (en) 1991-10-31
PT97369A (pt) 1991-12-31
DE69100991D1 (de) 1994-02-24
DK0477333T3 (da) 1994-03-14
CA2058946A1 (en) 1991-10-18
JPH05500674A (ja) 1993-02-12
HK12495A (en) 1995-02-03
IE911272A1 (en) 1991-10-23
AU7681291A (en) 1991-11-11
ES2048594T3 (es) 1994-03-16
KR920702618A (ko) 1992-10-06
NZ237824A (en) 1992-03-26
EP0477333B1 (en) 1994-01-12
IT9020055A1 (it) 1991-10-17

Similar Documents

Publication Publication Date Title
DK0477333T3 (da) Farmaceutiske præparater
GR3001238T3 (en) Process for the preparation of an administration and dosage for drugs, reagents or other active substances
CA2033277A1 (en) Controlled release pharmaceutical preparation and method for producing the same
ES2174849T3 (es) Composiciones farmaceuticas con sabor agradable.
SE9500422D0 (sv) New oral pharmaceutical dosage forms
RU94045950A (ru) Фармацевтический препарат и способ его приготовления
FI92648C (fi) Menetelmä peroraalisen terapeuttisen järjestelmän valmistamiseksi vaikeasti liukeneville vaikuttaville aineille
IS4329A (is) Fjöleiningaskammtar í töfluformi sem innihalda prótónupumpublokkara
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
SE9600073D0 (sv) Multiple unit dosage form
ES2152485T3 (es) Procedimiento para preparar comprimidos que contienen amoxicilina y clavulanato recubiertos de una pelicula polimerica acuosa.
MA23170A1 (fr) Procede de preparation d'un nouveau compose .
EP0382077A3 (de) Diarylsubstituierte heterocyclische Verbindung, ihre Herstellung und Arzneimittel und Kosmetika daraus
AU3533395A (en) Oral sustained-release preparation
TR199701294T1 (xx) Amoksisilin ve klavulanik asitten olu�an terkip.
IT1153487B (it) Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
ATE139690T1 (de) Ein ibuprofen enthaltendes akut-arzneimittel und seine verwendung
SE9003904D0 (sv) Method for the manufacture of a pharmaceutical dosage form
ATE110723T1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
DK0615443T3 (da) Lægemiddel i akut virksom form indeholdende Flurbiprofen og anvendelse deraf
EE03954B1 (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod
GB2333042A (en) Colonic delivery of weak acid drugs
HUP9802005A2 (hu) Nátrium/hidrogén-csere inhibitorok alkalmazása különböző anyagok által a szívre gyakorolt nem kívánt hatások csökkentésére alkalmas gyógyszerkészítmények előállítására
ATE155683T1 (de) Arzneimittel zur verhinderung der toleranzentwicklung während der behandlung mit benzodiazepin-rezeptor-bindenden wirkstoffen
JO1881B1 (en) Formula II for multi unit disc calibration

Legal Events

Date Code Title Description
0001 Granted